Talzenna 1 mg/1

Talzenna 1 mg capsules are a pharmaceutical product containing talazoparib, used for specific medical conditions. This oral medication is manufactured by Pfizer Laboratories and is available in a 30-capsule bottle.

Talzenna 1 mg capsules are primarily used in the management of certain types of cancer. Talazoparib, the active ingredient, is a PARP inhibitor that works by targeting specific enzymes involved in DNA repair. This medication is often prescribed for conditions where genetic mutations affect DNA repair mechanisms, such as in BRCA-mutated cancers. Patients should consult their healthcare provider to understand what is Talzenna used for in their specific case.

Common effects of Talzenna 1 mg capsules may include fatigue, nausea, and anemia. Some individuals might experience vomiting, decreased appetite, or hair loss. These effects can vary in severity and duration. It is important to monitor any adverse reactions and discuss them with a healthcare professional.

Talzenna 1 mg capsules should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the capsules out of reach of children and pets. Always follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not share this medication with others.

Talzenna 1 mg capsules may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol consumption should be discussed with your healthcare provider, as it may affect the efficacy or safety of the medication.